SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-24-000089
Filing Date
2024-08-13
Accepted
2024-08-13 16:31:11
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20240630.htm   iXBRL 10-Q 934933
2 EX-31.1 exicureexhibit311-63024.htm EX-31.1 7750
3 EX-31.2 exicureexhibit312-63024.htm EX-31.2 7762
4 EX-32.1 exicureexhibit321-63024.htm EX-32.1 8231
  Complete submission text file 0001698530-24-000089.txt   5421065

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20240630.xsd EX-101.SCH 45288
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20240630_cal.xml EX-101.CAL 50598
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20240630_def.xml EX-101.DEF 164288
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20240630_lab.xml EX-101.LAB 583166
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20240630_pre.xml EX-101.PRE 379781
76 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20240630_htm.xml XML 564735
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 241202189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)